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ABSTRACT

ARTICLE HISTORY

Wastewater-based epidemiology is an innovative approach that uses the analysis of
human excretion products in wastewater to obtain information about exposure to drugs in
deﬁned population groups. We developed and validated an analytical method for the
simultaneous determination of opioids (morphine, oxycodone, hydrocodone, oxymorphone
and hydromorphone), and cannabinoids (D9-tetrahydrocannabinol, 11-nor-9-carboxytetrahydrocannabinol (THCCOOH) and THCCOOH-glucuronide) in raw-inﬂuent wastewater
samples by ultra-high performance liquid chromatography-tandem mass spectrometry.
Method validation included linearity (5–1 000 ng/L for opioids, 10–1 000 ng/L for
cannabinoids), imprecision (<21.2%), accuracy (83%–131%), matrix effect (from –35.1% to
–14.7%) and extraction efﬁciency (25%–84%), limit of detection (1–5 ng/L) and quantiﬁcation
(5–10 ng/L) and auto-sampler stability (no loss detected). River and wastewater samples were
collected in triplicate from different locations in New York City and stored at ¡20  C until
analysis. Water from sewage overﬂow location tested positive for morphine (10.7 ng/L),
oxycodone (4.2–23.5 ng/L), oxymorphone (4.8 ng/L) and hydromorphone (4.2 ng/L). Raw
inﬂuent wastewater samples tested positive for morphine (133.0–258.3 ng/L), oxycodone (31.1–
63.6 ng/L), oxymorphone (16.0–56.8 ng/L), hydromorphone (6.8–18.0 ng/L), hydrocodone (4.0–
12.8 ng/L) and THCCOOH (168.2–772.0 ng/L). This method is sensitive and speciﬁc for opioids
and marijuana determination in wastewater samples.
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Introduction
Wastewater analysis is the method of choice for determining what drug(s) are being used in the geographical
areas that wastewater treatment plants service [1]. By
observing human biomarkers in sewage water, analysts
can monitor the consumption of various drugs. These
ﬁndings can then be compared to, and even supplement, traditional anonymous surveys. Wastewater epidemiology/toxicology is inexpensive, provides virtually
real-time data, and is reliable for assessing the extent
of drug use in a geographical region of interest. Its ability to rapidly determine drug use trends in an area can
help with the development of targeted public health
programs and policy initiatives in these speciﬁc communities. However, some disadvantages of wastewater
analysis include uncertainties because of population
ﬂow variations (e.g. with visitors and tourists), sewage
ﬂow changes, rainfall, and varying inter-individual
drug excretion rates [2,3]. Whereas wastewater analysis
is a rapidly growing ﬁeld in Europe [4], data for the
evaluation of raw inﬂuent wastewater in the United
States (USA) are scarce [2,5]. This type of study has
never been performed in New York City (NYC), which
is the largest city in the USA.
Prescription opioids are used to treat chronic pain,
and their use has increased dramatically in recent
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years. This has been strongly associated with increasing rates of nonmedical use of prescription opioids in
the USA [6]. This situation has led to opioids being the
most abused class of prescription drugs [7]. According
to statistics from the New York City Health Department, 59 opioid-related deaths occurred in 2000, and
this increased to 220 opioid-related deaths in 2013 [8].
Between 2005 and 2014, the rate of deaths because of
prescription opioid increased 250% (rate of increase
per 100 000 general population). In 2005, prescription
opioids contributed to 29% of the drug overdoses in
New York, and this ﬁgure rose to 43% by 2014 [9].
According to the 2014 National Survey on Drug Use
and Health [10], 4.3 million people aged 12 or older
have reported current nonmedical use of prescription
pain relievers.
In the USA, marijuana is the most commonly used
illicit drug, with 22.2 million marijuana users aged 12
or older that have used the drug in the past month
(past-month users) [10]. This is followed by stimulants
(1.6 million past-month users), cocaine (1.5 million
past-month users) and heroin (400 000 past-month
users). Based on National Statistics, 44% of adolescents
12 years and older have used marijuana in their lifetime,
which is about the same percentage as individuals aged
26 and older. Individuals aged 18 to 25 years old have
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the highest percentage of marijuana users (52%) [11].
On July 7 2014, New York became the 23rd state to
legalize medical marijuana [12], allowing medical facilities in eight cities to prescribe capsules, liquids, oils, or
vaporizable forms of cannabis. The effect of marijuana
legalization on prevalence of use is still unknown.
Several authors have published methods for the determination of licit and illicit drugs in wastewater [13–28].
However, prescription opioid data are scarce, and
wastewater samples have never been analysed
for the major cannabis metabolite in human urine,
11-nor-9-carboxy-tetrahydrocannabinol-glucuronide
(THCCOOH-glucuronide). The objective of this
study was to develop and validate an analytical method
for the detection of morphine, common prescription
opioids (oxycodone, oxymorphone, hydrocodone and
hydromorphone) and cannabinoids in wastewater samples. Then, for proof of concept, this method was
applied to river water and raw inﬂuent wastewater samples collected from different locations within NYC.

Materials and methods
Reagents and materials
Morphine, oxycodone, hydrocodone, oxymorphone,
hydromorphone, D9-tetrahydrocannabinol (THC) and
its metabolites 11-nor-9-carboxy-tetrahydrocannabinol
(THCCOOH) and THCCOOH-glucuronide were purchased from Cerilliant (Round Rock, TX, USA).
The deuterated analogs THC-d3, THCCOOH-d3,
THCCOOH-glucuronide-d3, morphine-d3, oxycodoned6, hydrocodone-d6, oxymorphone-d3 and hydromorphone-d6 were also purchased from Cerilliant. Strata
XC 33 mm polymeric strong cation exchange cartridges
of 3 mL/60 mg for calibrators and 6 mL/200 mg for
quality control (QC) and authentic wastewater samples
were purchased from Phenomenex (Torrance, CA,
USA). Ultra-high performance liquid chromatography
(UHPLC) grade methanol, dichloromethane and
ammonium hydroxide were purchased from PharmcoAaper (Brookﬁeld, CT). Isopropanol, liquid chromatography mass spectrometry grade acetonitrile, and Whatman glass microﬁber ﬁlters (outside diameter 4.7 cm,
particle retention 1.6 mm, and thickness 0.26 mm) were
from Thermo Fisher Scientiﬁc (Waltham, MA, USA).
Instrumentation
The chromatographic separations were carried out on
an UHPLC–tandem mass spectrometry (MS/MS)
instrument from Shimadzu (Kyoto, Japan). The Nexera UHPLC system consisted of a binary LC-20ADXR
high-performance liquid chromatography pump, Nexera LC-30AD micro mixer, online degassing unit
(DGU-20A3R) and cooled autosampler (SIL-20SCHT
UFLC). The chromatographic column was a Kinetex
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C18 (2.1 mm £ 100 mm, 1.7 mm particle size, 100 A
pore size) and the guard column was a SecurityGuard
ULTRA Cartridges C18(2.1 mm £ 2 mm, Phenomenex). Mobile phase A was 0.1% formic acid in water
and mobile phase B was 0.1% formic acid in acetonitrile. The following gradient program was used for elution of cannabinoids: held at 40% B for 4 min,
increased to 95% B and held for 1 min, decreased to
40% B in 0.5 min and held at 40% B for 1.5 min. The
total run time was 7 min and the mobile phase ﬂow
rate was 0.5 mL/min. The following gradient program
was used for elution of opioids: held at 2% B for 1 min,
increased to 30% B in 3 min, increased to 95% B in
2 min and held for 1 min, decreased to 2% B in
0.5 min and held for 2.5 min. The total run time was
10 min and the mobile phase ﬂow rate was 0.3 mL/min.
The column oven was operated at 40  C. The injection
volume was 50 mL for each set of compounds.
The mass spectrometer was a triple quadrupole LCMS 8030 from Shimadzu equipped with a dual ionization source (atmospheric pressure chemical and electrospray ionization). The nebulizing gas ﬂow was set to
2 L/min, the desolvation line was at 250  C, the heating
block was at 400  C and the drying gas ﬂow was at
15 L/min. The dual ionization source corona needle
voltage and interface voltage were both set to 4.5 kV.
Two multiple reaction monitoring (MRM) transitions
were monitored for each compound (Table 1), with
one used as a quantiﬁer and the other as a qualiﬁer.
Sample preparation
An aliquot (100 mL) of each wastewater sample was
measured using a graduated cylinder and placed in a
beaker, spiked with 50 mL of internal standard mixture
(0.1 mg/mL), and ﬁltered through a glass microﬁber ﬁlter. Then, 0.5 mL of HCl was added immediately to
acidify the solution to maximize retention onto mixedmode cartridges.
Solid phase extraction
Strata XC 6 mL/200 mg cartridges were conditioned
with 6 mL of methanol and then 6 mL of ultra-high
purity (UHP) water, and 6 mL of 0.1% HCl. Then the
100 mL of acidiﬁed wastewater was manually loaded
6 mL at a time (17 times) onto a cartridge with a small
vacuum (<34 473 Pa). The cartridges were washed
with 4 mL of UHP water and 4 mL of 0.1% HCl, and
then dried under vacuum for 15 min. Finally,
8 mL of elution solvent (Vdichloromethane:Visopropanol:
Vammonium hydroxide D 78:20:2) was added. A vacuum
was applied to retrieve all the solvent, and the eluate
was split in half. The opioid samples were labelled set 1,
and the cannabinoid samples were labelled set 2. Each
set was evaporated to dryness under a steady stream of
N2 in a Biotage TurboVap (Uppsala, Sweden) at 40  C.
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Table 1. Multiple reaction monitoring transitions, retention time (RT) and precursor ion for each analyte of interest.
Compound
RT (min)
Morphine
3.14
Morphine-d3
3.13
Hydromorphone
3.44
3.42
Hydromorphone-d6
Oxymorphone
3.29
3.29
Oxymorphone-d3
Oxycodone
3.98
3.97
Oxycodone-d6
Hydrocodone
4.10
4.08
Hydrocodone-d6
THC
4.01
4.00
THC-d3
THCCOOH
2.87
2.86
THCCOOH-d3
THCCOOH-glucuronide
1.98
1.94
THCCOOH-glucunoride-d3
1)
2)

Precursor ion
(m/z)
286
289
286
292
302
304
316
322
300
306
315
318
345
348
521
524

Quantiﬁer product
ion (m/z)
165
164
184
185
226
201
256
247
199
202
193
195
299
330
345
348

Collision energy1)
(eV)
¡40
¡44
¡33
¡33
¡32
¡45
¡26
¡31
¡31
¡36
¡23
¡27
¡21
¡17
¡15
¡15

Qualiﬁer product
ion (m/z)
181
153
157
157
242
230
212
262
170
174
122
122
192
302
326
330

Collision energy2)
(eV)
¡33
¡43
¡43
¡49
¡28
¡31
¡46
¡29
¡40
¡44
¡38
¡39
¡28
¡23
¡18
¡21

Collision energy for Quantiﬁer production.
Collision energy for Qualiﬁer production.

The opioid samples (set 1) were reconstituted in 200 mL
of UHP water, and the cannabinoid samples (set 2)
were reconstituted in 200 mL of a mixture (VA:VB D
60:40) of mobile phases A (0.1% formic acid in water)
and B (0.1% formic acid in acetonitrile).
Calibrators, quality controls and internal
standards
An internal standard working solution was prepared by
diluting each ampoule with pure methanol and combining all analogues to a ﬁnal concentration of 0.1 mg/mL
in methanol. Standard working solutions were prepared
in pure methanol to a stock concentration of 1 mg/mL,
and then serially diluted to concentrations of 0.1 and
0.01 mg/mL in pure methanol. Calibration working
solution mixtures, containing all compounds of interest,
were also prepared in methanol to concentrations of
0.001, 0.01, 0.1, and 1 mg/mL. These solutions were
used to prepare standard curve solutions at concentrations of 0.5, 1, 3, 5, 10, 50, 100, 500 and 1 000 ng/L.
To reduce the cost and time of this process, calibrators were prepared in 3 mL of UHP water spiked with
the corresponding calibration working solution to
match the amounts of 5 to 1 000 ng/L in 100 mL of
sample. For the calibration curve, clean test tubes were
prepared containing 3 mL of UHP water, 50 mL of
internal standard mixture (0.1 mg/mL), and the following volumes of the respective calibrator working
solution: 50 and 100 mL of the 0.01 mg/mL solution
for 5 and 10 ng/L calibrators, 50 and 100 mL of the
0.1 mg/mL solution for 50 and 100 ng/L calibrators,
and 50 and 100 mL of the 1 mg/mL solution for 500
and 1 000 ng/L calibrators. Lastly, 15 mL of HCl (0.5%)
was added before vortex mixing and solid phase
extraction (SPE). Strata XC 3 mL/60 mg cartridges
were conditioned with 3 mL of methanol, followed by
3 mL of UHP water and 3 mL of 0.1% HCl. The acidiﬁed calibrator was loaded onto the mixed-mode cartridge. Cartridges were washed with 2 mL of UHP

water and 2 mL of 0.1% HCl, and then dried under
vacuum for 15 min. Sample elution was performed
with 4 mL of a dichloromethane/isopropanol/ammonium hydroxide mixture (Vdichloromethane:Visopropanol:
Vammonium hydroxide D 78:20:2). The eluate was split in
half. The samples were labelled as set 1 for opioids and
set 2 for cannabinoids. Each set was evaporated to dryness under a steady stream of N2 in a Biotage TurboVap at 40  C. Opioid samples (set 1) were reconstituted
in 200 mL of UHP water, and cannabinoids samples
(set 2) were reconstituted in 200 mL of a mixture
(VA:VB D 60:40) of mobile phases A (0.1% formic acid
in water) and B (0.1% formic acid in acetonitrile).
QC samples were prepared at 10 and 100 ng/L by
spiking 100 mL of UHP water with the required
amount of the working solution and 50 mL of the internal standard mixture. These samples were then ﬁltered,
and 0.5 mL of HCl (0.5% HCl) was added before SPE.
Sample collection
For proof of concept, 33 samples were collected from
river water (22 samples), sewage overﬂow (6 samples)
and raw inﬂuent from wastewater treatment plants
(5 samples) in NYC. River samples were collected from
the Hudson and East Rivers in the Bronx, Manhattan,
Queens and Roosevelt Island. Sewage overﬂow samples
were collected from Newtown Creek (Brooklyn), and
wastewater samples were collected from the Tallman
and Jamaica wastewater treatment plants in Queens.
Samples were collected for 1–3 days before and after
national holidays (Independence Day, July 4 2015;
Labor Day, September 7 2015; New Year’s Day, January
1 2016) and on March 25th and 30th 2016. The samples were collected at one time on each of these days
(between 7 and 11 am) in 200 mL NalgeneTM Certiﬁed
Wide-Mouth Amber high-density polyurethane bottles
(Thermo Fisher Scientiﬁc). To prevent degradation of
the target drugs, the samples were stored in a freezer at
–20  C until required for analysis.
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Validation parameters
The method was validated using various procedures
outlined by the Scientiﬁc Working Group for Forensic
Toxicology guidelines [29] for the linearity, limit of
detection (LOD), limit of quantiﬁcation (LOQ), interferences (speciﬁcity), autosampler stability, imprecision, accuracy, carryover, extraction efﬁciency, process
efﬁciency and matrix effect.
Linearity was determined over ﬁve different days by
least-squares regression and different weighting factors
(none, 1/x and 1/x2) were evaluated. The linearity was
acceptable if the coefﬁcient of determination (R2) was
 0.99 and the residuals were within §20%. The LOD
and the LOQ were evaluated with decreasing analyte
concentrations in spiked samples from three different
sources. The LOD was the lowest concentration with
acceptable chromatographic parameters, a signal-tonoise ratio > 3, the presence of all product ions, the
correct ion ratio (within §20% from the average of the
calibrators) and a suitable retention time (within
§0.2 min of the retention time of the calibrators). The
LOQ satisﬁed the LOD criteria and was quantiﬁed
within §20% imprecision and 80%–120% accuracy.
Interferences from matrix components were evaluated by analysing river (n D 22) and wastewater (n D 4)
samples negative for the compounds of interest, after
spiking with the internal standard solution. Interferences were considered insigniﬁcant if the analytes of
interest were not detected in these samples. Method
speciﬁcity was demonstrated by analysing high concentrations (1 000 ng/L) of potentially interfering drugs.
The following compounds and their metabolites
were examined: opioids (morphine-3-glucuronide,
morphine-6-glucuronide, hydromorphone-3-glucuronide, oxymorphone-3-glucuronide, oxymorphone6-glucuronide and 6-acetylmorphine), cannabinoids
(11-hydroxy-THC, cannabinol, and cannabidiol) and
common drugs of abuse (cocaine, benzoylecgonine,
amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine, 3,4-methylenedioxymethamphetamine
and methadone). Sufﬁcient speciﬁcity was achieved if
the analytes of interest were below the LOD.
To determine carryover, blank samples spiked
with the internal standard (negative calibrator)
were injected immediately after samples spiked at
2 000 ng/L (twice the highest calibrator concentration).
The carryover was considered negligible if the measured concentration was less than the LOD. Before
SPE, the 2 000 ng/L samples were prepared using 3 mL
of UHP water and spiking it with 50 mL of internal
standard, 200 mL of the 1 mg/mL calibrator solution
and 15 mL of HCl.
Inter- and intra-day QC samples at 10 ng/L and
100 ng/L were prepared in 100 mL of UHP water
spiked with 100 mL of the 0.01 mg/mL solution (for
10 ng/L concentration) or the 0.1 mg/mL solution
(for 100 ng/L concentration). The imprecision and
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accuracy were determined at these two concentrations
with four repeat analyses on one day (intra-day n D 4)
and over ﬁve days (inter-day n D 5). The imprecision
was determined using the coefﬁcient of variation of the
measured values and expected to be less than 20%. The
intra- and inter-day imprecision were calculated as the
standard deviation of the QC concentrations £ 100/
mean QC concentrations. The accuracy was calculated
as a percentage of the target concentration, and was
required to be within 80%–120%. The intra- and interday accuracy was calculated as the mean QC concentrations £ 100/QC target concentration.
Autosampler stability was evaluated by reinjecting
four QC samples after 24 h in the autosampler at
10  C. The QC samples were prepared at 10 ng/L using
100 mL of UHP water and 100 mL of 0.01 mg/mL calibrator working solution. The concentrations within
§20% of the initial concentration were considered
acceptable.
To evaluate the matrix effect, extraction efﬁciency
and process efﬁciency, three sets of samples were
prepared in duplicate at the same concentration
(10 ng/L). Set 1 contained neat samples prepared by
adding 2 mL of elution solvent, 50 mL of internal standard, and 100 mL of the 0.01 mg/mL solution to a clean
test tube. This sample was then split equally, evaporated to dryness and reconstituted in the appropriate
opioid or cannabis mobile phase for LC-MS/MS separation and analysis. Set 2 contained QC samples spiked
at 10 ng/L with the internal standard and submitted to
the same sample preparation and extraction steps as
above. Set 3 contained QC samples spiked at 10 ng/L
and with the internal standard post-extraction. The
samples were from four different sources, including
samples prepared with UHP water (one set) and using
authentic wastewater samples that tested negative for
the target drugs (three sets). The peak areas for Set 1
and 3 were compared to determine if there were any
matrix effects. The peak areas for the Set 2 and 3 samples were compared to assess the extraction efﬁciency,
and those for Set 1 and Set 2 were used to assess the
process efﬁciency.
Identiﬁcation criteria
The identiﬁcation criteria included a retention time
within §0.2 min of the calibrator retention time, the
presence of two product ions (quantitative and qualitative) and an ion ratio within §20% from the average of
the calibrators.

Results
Method validation
The LOQ and LOD for all opioids were 5 and 1 ng/L,
respectively, and the linear range was 5–1 000 ng/L.
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For the cannabinoids, the LOQ, LOD and linear range
were 10, 5 and 10–1 000 ng/L, respectively. Acceptable
linearity for opioids and cannabinoids (R2  0.99 and
residuals within §20%) were achieved with 1/x2
weighting. No endogenous or exogenous interferences
were detected.
For opioids, the intra- and inter-day imprecision
were 3.3% to 14.1%, respectively, and the accuracy was
93.3%–131.0%. For cannabinoids, the intra and interday imprecision were 4.1% to 21.2%, respectively, and
the accuracy was 83.0% to 119.3%. For opioids, the
extraction efﬁciency range was 75.0%–84.0%, and the
process efﬁciency range from 63.1% to 73.3%. For cannabinoids, the extraction efﬁciency range was 25.4%–
66.5% and the process efﬁciency range was 22.7%–
62.7%. For opioids, the matrix effects range was
–35.1% to –7.6% (ion suppression), with a coefﬁcient
of variation of  28.3% (n D 4). For cannabinoids, the
matrix effects range was –14.7% to –5.8%, with a coefﬁcient of variation of  13.9% (n D 4). These results
are summarized in Tables 2 and 3.
Carryover was assessed by injecting a blank after
injection of a sample prepared at 2 000 ng/L (twice the
concentration of our highest calibrator). The results
for all target compounds for the blank were below
LOD, which means that all extracted compounds are
eluted before injection of the next sample. Autosampler stability was assessed by injecting the same both
fresh and after 24 h in the autosampler at 10  C. The
mean concentrations from these injections were compared to determine the percentage difference. The concentrations of all target compounds were within the
accepted 20%, except for oxymorphone (–21.3%).

Table 3. Extraction efﬁciency, process efﬁciency, matrix effect
and coefﬁcient of variation for each analyte at 10 ng/L.

Application to authentic samples

Table 4. Results from raw input wastewater plants (Tallman
and Jamaica, New York City, NY) collected at one time point 1–
3 days before and after national holidays (Independence Day,
July 4 2015; Labor Day, September 7 2015; New Year’s Day,
January 1 2016) and in March 2016.

Samples from the East and Hudson rivers tested negative
for morphine, prescription opioids and cannabis. Samples from sewage overﬂows (Newtown Creek, Brooklyn)
tested positive for morphine (10.7 ng/L), oxycodone
(4.2–23.5 ng/L), oxymorphone (4.8 ng/L) and hydromorphone (4.2 ng/L). Raw inﬂuent wastewater samples
from the Tallman and Jamaica plants in Queens tested
positive for morphine (133.0–258.3 ng/L), oxycodone
(31.1–63.6 ng/L), oxymorphone (16.0–56.8 ng/L),

Compound
Morphine
Oxymorphone
Hydromorphone
Oxycodone
Hydrocodone
THC
THCCOOH
THCCOOH-glucuronide

Extraction
efﬁciency (%)
79.0
84.0
75.0
82.0
84.0
25.4
66.5
53.1

Process
efﬁciency (%)
73.3
63.1
48.8
63.5
72.6
22.7
62.7
45.3

Matrix
effect (%)
¡7.6
¡24.5
¡35.1
¡23.1
¡13.8
¡10.6
¡5.8
¡14.7

hydromorphone (6.8–18.0 ng/L), hydrocodone (4.0–
12.8 ng/L) and THCCOOH (168.2–772.0 ng/L) (Table 4).
Figure 1 shows a chromatogram of an authentic wastewater sample that tested positive for opioids and
cannabinoids.

Discussion
We developed and validated a method for the simultaneous analysis of morphine, oxymorphone, oxycodone, hydromorphone, hydrocodone, THC and its
metabolites THCCOOH and THCOOH-glucuronide
in wastewater samples. Numerous methods for the
determination of licit and illicit drugs in wastewater
samples have been published [13–28]. These analytical
methods allow for the determination of opiates and
prescription opioids [14,18,25,27,28], cannabis [16,19]
or both classes of compounds, opiates and cannabis [13,15,18–20,21,22,24,26]. In the case of opiates,
most of the methods can only detect
morphine [13–15,17,18,20,21–26,28], although some
methods are suitable for prescription opioids such
as oxycodone, oxymorphone, hydrocodone and

Analyte
Morphine
Hydrocodone
Oxycodone
Oxymorphone
Hydromorphone
THCCOOH

Concentration range (ng/L)
133.0 – 258.3
4.0 – 12.8
31.1 – 63.6
16.0 – 56.8
6.8 – 18.0
168.2 – 772.0

N cases
5
4
5
5
5
5

Table 2. Inter- and intra-day imprecision and accuracy for quality controls at 10 and 100 ng/L.

Compound
Morphine
Oxymorphone
Hydromorphone
Oxycodone
Hydrocodone
THC
THCCOOH
THCCOOH-glucuronide

Imprecision (%)
Inter-day (n D 5)
Intra-day (n D 4)
10 (ng/L)
100 (ng/L)
10 (ng/L)
100 (ng/L)
11.4
6.2
5.6
3.4
10.8
3.9
4.9
3.3
14.1
3.3
12.9
4.4
8.9
7.6
10.9
5.0
10.0
8.8
6.1
4.8
9.7
9.0
21.2
7.9
8.0
6.1
5.0
7.3
6.0
10.2
4.1
5.5

Accuracy (%)
Inter-day (n D 5)
Intra-day (n D 4)
10 (ng/L)
100 (ng/L)
10 (ng/L)
100 (ng/L)
93.3
94.7
116.0
110.9
106.5
106.6
126.5
109.1
98.3
103.3
119.5
121.1
98.3
101.1
110.0
102.0
107.5
103.7
131.0
127.2
102.8
98.8
110.3
106.6
97.3
105.6
119.3
103.4
95.0
98.9
83.0
102.3
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Figure 1. Multiple reaction monitoring chromatograms of an authentic wastewater sample from Tallman Island Wastewater Treatment Plant (Queens, NYC) showing positive results for THCCOOH (184.1 ng/L), morphine (181.9 ng/L), hydromorphone (10.0 ng/L),
oxymorphone (56.8 ng/L), oxycodone (63.3 ng/L) and hydrocodone (10.3 ng/L).

hydromorphone [14,18,19,25–28]. With regard to cannabis, most methods have been developed for
THCCOOH [15,16,19,22,24] or for THC or THC and
THCCOOH [13,17,20,21,23,26]. There is no data
available for THCCOOH-glucuronide in wastewater
samples, even though this compound is the predominant THC metabolite in human urine [30]. This may
be because glucuronides are normally hydrolysed in
wastewater [31], resulting in higher concentrations of
the free compound. However, recent publications have
reported high concentrations of glucuronides in wastewater samples [32,33]. These results highlight the need
for a method for detection of glucuronides in
wastewater.
Currently, the method most commonly used for
wastewater analysis is LC-MS/MS. However, gas chromatography-mass spectrometry has been used
too [34]. In the present method, all compounds were
ionized in positive mode (atmospheric pressure chemical/electrochemical ionization dual source), despite
other authors ﬁnding better sensitivity for cannabinoids in negative ionization mode (electrochemical
ionization) [13,15,21,24]. The sensitivity of our
method (LOD 1–5 ng/L and LOQ 5–10 ng/L in
100 mL of wastewater) was within the range of methods in previous publications [19,20,22,25]. Earlier
studies have reported LOQs for the compounds of
interest as low as 0.48 ng/L [35] and as high as
100 ng/L [22] for wastewater volumes between
15 mL [28] and 250 mL [17]. Sample preparation

usually involves ﬁltration and SPE with a reversedphase (Oasis HLB, Waters Corp., Milford, MA, USA)
or cation exchange (Oasis MCX, Waters Corp.)
cartridges.
During method validation, matrix effect experiments were carried out using four different matrices
instead of six [29]. This limitation was because it was
difﬁcult to obtain wastewater samples that were negative for the compounds of interest. Another limitation
of the present method was the intra-day accuracy
above the established criteria for three opioids.
Although oxymorphone’s low QC, hydromorphone’s
high QC and hydrocodone’s low and high QC gave an
intra-day accuracy >120% (121.1% to 131%), the rest
of the validation parameters were within the established range [29].
As a proof of concept, we were able to detect
THCCOOH, morphine and prescription opiates in water
samples from sewage overﬂow locations and wastewater
treatment plants. The concentrations of morphine (10.7–
258.3 ng/L), oxycodone (4.2–63.6 ng/L), oxymorphone
(4.8–56.8 ng/L), hydromorphone (4.2–18.0 ng/L),
hydrocodone (4.0–12.8 ng/L) and THCCOOH
(168.2–772.0 ng/L) were similar to those found in previous studies [18,19,28,29,33]. THC and THCCOOH-glucuronide were not detected in any of the analysed
samples. Previously, THC was detected in wastewater
samples [17], but there are no reports of the detection of
THCCOOH-glucuronide. Continued research is
required to investigate the importance of monitoring
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THCCOOH-glucuronide’s in these types of samples, and
to back calculate the drug exposure in communities
based on wastewater drug concentrations.

Conclusion
We developed and validated an analytical method for
the simultaneous determination of morphine, common
prescription opioids (oxycodone, oxymorphone,
hydrocodone and hydromorphone), and cannabis and
its metabolites in wastewater samples. This technique
is sensitive (LOD 1–5 ng/L and LOQ 5–10 ng/L in
100 mL of sample) and speciﬁc. This is the ﬁrst report
of testing for THCCOOH-glucuronide in wastewater
samples. As a proof of concept, we were able to detect
THCCOOH, morphine, and prescription opioids in
samples from sewage overﬂow locations and wastewater plants throughout NYC.
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